https://scholars.lib.ntu.edu.tw/handle/123456789/580191
標題: | Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study | 作者: | CHING-HUNG LIN Chuang P.-Y. CHUN-JU CHIANG YEN-SHEN LU ANN-LII CHENG WEN-HUNG KUO CHIUN-SHENG HUANG Lai M.-S. You S.-L. Tang C.-H. |
公開日期: | 2014 | 出版社: | AlphaMed Press | 卷: | 19 | 期: | 6 | 起(迄)頁: | 583-591 | 來源出版物: | Oncologist | 摘要: | Background. Arapid surge of young-female breast cancer (YFBC) has been observed in Taiwan and other East Asian countries. We recently reported that these cases of YFBC, in contrast to their Western counterparts, are predominantly luminal A subtype. YFBC in Asia may have distinct clinicopathological features and out comes. Methods. Data collected prospectively by participating hospitals were retrieved from the Taiwan Cancer Database. A total of 15,881 women with newly diagnosed stage I-III breast cancer in 2002-2006 were included. The age at diagnosis was categorized into nine 5-year groups (from < 30 years to ? 65 years). Clinicopathological variables and patient disease-free survival (DFS) were compared by age group. Results. The rates of stage I, estrogen receptor-positive (ER+), and progesterone receptor-positive breast cancer were higher in the younger patients (< 50 years) than in the older patients (? 50 years). Univariate analysis showed that the 40-44 and 45-49 age groups were significantly associated with longer DFS than the other age groups. In the ER+ subgroup, multivariate analysis consistently showed that the 40-44 age group was significantly associated with longer DFS than the other age groups except for the 45-49 age group. In contrast, multivariate analysis of the ER-negative subgroup revealed no significant difference of DFS between the 40-44 age group and other age groups. Conclusion. Emerging YFBC in Taiwan is uniquely associated with favorable pathological features and better outcomes and should not be regarded as the mirror image of its Western counterpart. ? AlphaMed Press 2014. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901927747&doi=10.1634%2ftheoncologist.2014-0047&partnerID=40&md5=3981ff045419e9f8135109e506dd8b37 https://scholars.lib.ntu.edu.tw/handle/123456789/580191 |
DOI: | 10.1634/theoncologist.2014-0047 | SDG/關鍵字: | adolescent; adult; age; aged; article; axillary lymph node; breast cancer; cancer chemotherapy; cancer hormone therapy; cancer prognosis; cancer registry; cancer risk; cancer staging; clinical feature; controlled study; disease free survival; estrogen receptor positive breast cancer; female; hazard ratio; histology; human; major clinical study; middle aged; outcome assessment; pathology; priority journal; progesterone receptor positive breast cancer; tumor volume; very elderly; age; Breast Neoplasms; Far East; register; Adult; Age Factors; Aged; Breast Neoplasms; Disease-Free Survival; Far East; Female; Humans; Middle Aged; Neoplasm Staging; Registries |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。